283 related articles for article (PubMed ID: 27432858)
1. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
[TBL] [Abstract][Full Text] [Related]
2. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart.
Huntgeburth M; Tiemann K; Shahverdyan R; Schlüter KD; Schreckenberg R; Gross ML; Mödersheim S; Caglayan E; Müller-Ehmsen J; Ghanem A; Vantler M; Zimmermann WH; Böhm M; Rosenkranz S
PLoS One; 2011; 6(11):e26628. PubMed ID: 22125598
[TBL] [Abstract][Full Text] [Related]
4. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
5. Calcium/Calmodulin Protein Kinase II-Dependent Ryanodine Receptor Phosphorylation Mediates Cardiac Contractile Dysfunction Associated With Sepsis.
Sepúlveda M; Gonano LA; Viotti M; Morell M; Blanco P; López Alarcón M; Peroba Ramos I; Bastos Carvalho A; Medei E; Vila Petroff M
Crit Care Med; 2017 Apr; 45(4):e399-e408. PubMed ID: 27648519
[TBL] [Abstract][Full Text] [Related]
6. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
[TBL] [Abstract][Full Text] [Related]
7. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
9. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
[TBL] [Abstract][Full Text] [Related]
11. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
12. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling.
Zhang X; Szeto C; Gao E; Tang M; Jin J; Fu Q; Makarewich C; Ai X; Li Y; Tang A; Wang J; Gao H; Wang F; Ge XJ; Kunapuli SP; Zhou L; Zeng C; Xiang KY; Chen X
Circ Res; 2013 Feb; 112(3):498-509. PubMed ID: 23104882
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-Activated Protein Kinase and Intracellular Polyamine Signaling Is Involved in TRPV1 Activation-Induced Cardiac Hypertrophy.
Chen M; Xin J; Liu B; Luo L; Li J; Yin W; Li M
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473037
[TBL] [Abstract][Full Text] [Related]
16. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
[TBL] [Abstract][Full Text] [Related]
17. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.
Huang H; Tang QZ; Wang AB; Chen M; Yan L; Liu C; Jiang H; Yang Q; Bian ZY; Bai X; Zhu LH; Wang L; Li H
Hypertension; 2010 Aug; 56(2):232-9. PubMed ID: 20585109
[TBL] [Abstract][Full Text] [Related]
19. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.
Wang S; Gong H; Jiang G; Ye Y; Wu J; You J; Zhang G; Sun A; Komuro I; Ge J; Zou Y
PLoS One; 2014; 9(4):e92926. PubMed ID: 24699426
[TBL] [Abstract][Full Text] [Related]
20. Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy.
Traynham CJ; Cannavo A; Zhou Y; Vouga AG; Woodall BP; Hullmann J; Ibetti J; Gold JI; Chuprun JK; Gao E; Koch WJ
Circ Res; 2015 Dec; 117(12):1001-12. PubMed ID: 26515328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
